| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative) |
>0.5 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX)  |
462 |
| Staphylococci (coagulase-negative) |
>0.5 |
>8 |
0.12 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
462 |
| Staphylococci (coagulase-negative) |
1 |
1 |
0.12 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
472 |
| Staphylococci (coagulase-negative) |
>1 |
>1 |
≤0.5 － >1 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
123 |
| Staphylococci (coagulase-negative) |
1 |
1 |
0.5 － >4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1130 |
| Staphylococci (coagulase-negative) |
1 |
2 |
0.25 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
472 |
| Staphylococci (coagulase-negative) |
1 |
2 |
0.25 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
123 |
| Staphylococci (coagulase-negative) |
>1 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
472 |
| Staphylococci (coagulase-negative) |
1 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
6 |
| Staphylococci (coagulase-negative) |
1 |
3 |
? － ? |
Cefepime (Maxipime) |
123 |
| Staphylococci (coagulase-negative) |
1 |
4 |
0.5 － 8 |
FK037 |
1491 |
| Staphylococci (coagulase-negative) |
1 |
4 |
0.5 － 32 |
Cefpirome |
1491 |
| Staphylococci (coagulase-negative) |
>1 |
>4 |
≤1 － >2 |
Gentamicin (Gentamycin, Garamycin) |
462 |
| Staphylococci (coagulase-negative) |
1 |
4 |
? － ? |
Zosyn |
323 |
| Staphylococci (coagulase-negative) |
>1 |
>8 |
≤1 － >8 |
Imipenem |
462 |
| Staphylococci (coagulase-negative) |
1 |
16 |
0.06 － >=64 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
950 |
| Staphylococci (coagulase-negative) |
1.5 |
4 |
? － ? |
Cefotaxime (Cephotaxime, Claforan) |
323 |
| Staphylococci (coagulase-negative) |
>2 |
>2 |
≤0.06 － >2 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
472 |
| Staphylococci (coagulase-negative) |
>2 |
>2 |
≤0.25 － >2 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1130 |
| Staphylococci (coagulase-negative) |
>2 |
>2 |
≤0.25 － >2 |
Sparfloxacin (AT-4140, Zagam) |
123 |
| Staphylococci (coagulase-negative) |
2 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
189 |
| Staphylococci (coagulase-negative) |
2 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
6 |
| Staphylococci (coagulase-negative) |
≤2 |
≤2 |
≤2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
462 |
| Staphylococci (coagulase-negative) |
>2 |
>4 |
≤0.03 － >4 |
Levofloxacin (Levaquin, Quixin) |
472 |
| Staphylococci (coagulase-negative) |
2 |
4 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
189 |
| Staphylococci (coagulase-negative) |
2 |
8 |
≤0.12 － >16 |
Teicoplanin (Targocid) |
123 |
| Staphylococci (coagulase-negative) |
>2 |
>8 |
≤2 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
472 |
| Staphylococci (coagulase-negative) |
2 |
8 |
≤2 － >16 |
Teicoplanin (Targocid) |
472 |